Condition: Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Hormone Sensitive Prostate Cancer · Prostate Cancer · Sponsor: Pfizer
This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Clearview Cancer Institute (Crestwood) | Huntsville, Alabama, United States | Recruiting |
| Clearview Cancer Institute | Huntsville, Alabama, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Chandler, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Gilbert, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Glendale, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Goodyear, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Mesa, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Mesa, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Phoenix, Arizona, United States | Recruiting |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Scottsdale, Arizona, United States | Recruiting |
| Highlands Oncology Group, PA | Fayetteville, Arkansas, United States | Recruiting |
| Highlands Oncology Group, PA | Rogers, Arkansas, United States | Recruiting |
+ 329 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07028853